NICE commissioned an external assessment centre (EAC) to review the evidence submitted by the company. This section summarises that review. Full details of all the evidence are in the project ...
Laborie Announces First Procedures in ENDURE 1 Study with the Optilume® Ureteric Drug-Coated Balloon
Landmark procedures launch the ENDURE 1 clinical study evaluating Optilume's safety and feasibility as a new minimally invasive option for patients with benign ureteric strictures. PORTSMOUTH, N.H., ...
TUCSON, Ariz. (KVOA) — If you are a person that struggles with problems urinating then Carondelet St. Mary's may have an answer that doesn't require a surgical procedure. St. Mary's Hospital has ...
August 10, 2023 – Treatment with the recently approved, minimally invasive Optilume BPH device improves urinary symptoms while preserving sexual function in men with benign prostatic hyperplasia (BPH) ...
Optilume BPH is expected to have a significant global impact in urology, offering a novel alternative treatment option for enlarged prostate "We are proud at University Urology Associates to be ...
The committee noted that the clinical evidence showed Optilume to be effective in improving clinically relevant outcomes including anatomical success, peak flow rate and international prostate symptom ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results